Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Stroke. 2017 Jan 24;48(3):787–790. doi: 10.1161/STROKEAHA.116.015468

Table. Baseline characteristics and incidence of cardiovascular events in AF patients over 6 and 12 months.

Control Intervention
Baseline characteristics Median (IQR) unless indicated
List size 7039 (4724, 10832) 6803 (4071, 11368)
Prevalence of AF per 100 patients 1.71 (1.11, 2.20) 1.92 (1.77, 2.21)
Proportion of AF patients who are female 44.6% (40.9, 50.0) 46.3% (42.4, 50.0)
Proportion of AF patients under 80 years 56.5% (51.0, 62.3) 56.9% (51.6, 59.8)
Proportion eligible for OAC and prescribed OAC at baseline1 61.9% (9.89) 63.5% (8.85)
Events Incidence (patients with at least one event per 1000 AF patients) P Value2
Thromboembolic stroke, TIA or other major thromboembolism N=23 N=23
6 months 0 (0, 7.75) 10.3 (0, 16.3) 0.03
12 months 12.6 (0, 22.3) 14.5 (4.2, 26.1) 0.41
Haemorrhage (including haemorrhagic stroke)3 6 months 26.5 (15.0)1 21.0 (14.7)1 0.414
12 months 50.3 (33.4, 57.3) 34.7 (27.4, 43.6) 0.054
All cause stroke3 6 months 8.5 (0, 17.7) 7.9 (0, 13.4) 0.43
12 months 24.8 (19.3, 28.9) 15 (9.1, 28.3) 0.06
Transient ischaemic attack 6 months 0 (0,0) 6.4 (0, 12.2) 0.008
12 months 2.3 (0, 9.0) 10.0 (4.2, 18.2) 0.027
Thromboembolic stroke 6 months 0 (0, 0) 0 (0, 4.1) 0.40
12 months 0 (0, 12.8) 0 (0, 5.0) 0.36
Haemorrhagic stroke3 6 months 0 (0,0)1 0 (0,0)1 0.82
12 months 0 (0, 0.96) 0 (0, 3.14) 0.92
Unspecified stroke 6 months 5.2 (0, 16.4) 3.2 (0, 9.4) 0.26
12 months 17.0 (11.4)1 13.3 (11.0)1 0.394
1

Mean (SD)

2

Mann Whitney U test

3

N=22 in the control arm for haemorrhagic event searches (see Figure). The other searches were unaffected.

4

P value obtained from weighted linear regression.